Brief Research Report
Published on 19 Feb 2026
Treatment with Mirvetuximab-Soravtansin—first clinical experience in advanced ovarian cancer in a comprehensive cancer center
- 184 views
Brief Research Report
Published on 19 Feb 2026
Review
Published on 19 Feb 2026
Review
Published on 19 Feb 2026
Original Research
Published on 19 Feb 2026
General Commentary
Published on 19 Feb 2026
Review
Published on 19 Feb 2026
Case Report
Published on 19 Feb 2026
Original Research
Published on 19 Feb 2026
Systematic Review
Published on 19 Feb 2026
Case Report
Published on 19 Feb 2026
Original Research
Published on 19 Feb 2026
Review
Published on 19 Feb 2026
Original Research
Published on 19 Feb 2026
Review
Published on 19 Feb 2026
Case Report
Published on 19 Feb 2026
Case Report
Published on 19 Feb 2026
Case Report
Published on 19 Feb 2026
Systematic Review
Published on 19 Feb 2026
Original Research
Accepted on 18 Feb 2026
Original Research
Accepted on 18 Feb 2026
Original Research
Accepted on 18 Feb 2026
Case Report
Accepted on 18 Feb 2026
Case Report
Accepted on 18 Feb 2026
Original Research
Accepted on 18 Feb 2026